Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 0Sales per Share
VS
Market
Sector
Industry
History
$ 24.21Close
$ 11.02 - $ 25.71 52-Week Range
Ticker Information
Ticker
VRDNCompany Name
VIRIDIAN THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQVIRIDIAN THERAPEUTICS INC - Sales per Share Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
VRDN - SPS Historical data
| Date | Revenues | Share Factor | Weighted Average Shares | Sales per Share |
|---|---|---|---|---|
| 6/30/2025 | $ 305K | 1 | 81.59M | $ 0 |
| 3/31/2025 | $ 302K | 1 | 81.34M | $ 0 |
| 12/31/2024 | $ 302K | 1 | 67.89M | $ 0 |
| 9/30/2024 | $ 302K | 1 | 66.42M | $ 0 |
| 6/30/2024 | $ 288K | 1 | 63.85M | $ 0 |
| 3/31/2024 | $ 288K | 1 | 61.1M | $ 0 |
| 12/31/2023 | $ 314K | 1 | 44.76M | $ 0.01 |
| 9/30/2023 | $ 347K | 1 | 43.65M | $ 0.01 |
| 6/30/2023 | $ 1.47M | 1 | 43.25M | $ 0.03 |
| 3/31/2023 | $ 1.65M | 1 | 42.24M | $ 0.04 |
Key Performance Insights, Last 5 Years
- VIRIDIAN THERAPEUTICS INC's latest trailing twelve months (TTM) SPS stands at $ 0.5.
- Over the past 5 years, VIRIDIAN THERAPEUTICS INC's average SPS has been $ 0.11.
- The median SPS for VIRIDIAN THERAPEUTICS INC during this period was $ 0.04
- VIRIDIAN THERAPEUTICS INC reached its highest SPS over the past 5 years at $ 0.5.
- The lowest SPS recorded by VIRIDIAN THERAPEUTICS INC in the same timeframe $ 0
VIRIDIAN THERAPEUTICS INC's SPS vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
SPS Benchmarks
Similar metrics to SPS:
- Book Value per Share - [Calculation] The amount of equity attributed to each share, calculated as [Equity] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBITDA per Share - [Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Sales per Share
[Calculation] The amount of revenue attributed to each share, calculated as [Revenue] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].Revenues / (Shares WA * Share Factor)
(=) SPS SPS for VIRIDIAN THERAPEUTICS INC is calculated as follows: Revenues [ $ 1.88M ] / (Shares WA [ 3.72M ] * Share Factor [ 1 ])
(=) SPS [ $ 0.5 ] VRDN - Sales per Share, Last 5 years
$ 0
Minimum
Mar 31, 2025
$ 0.5
Maximum
Sep 30, 2020
$ 0.11
Average
$ 0.04
Median
SPS Benchmark AnalysisMarket
The chart above depicts the distribution of SPS for companies in the Total Stock Market. The average SPS of the companies is $ 11.53 with a standard deviation of $ 13.59.
The following table provides additional summary stats:
SPS in the Market:
| filtered constituents | 3.64K |
|---|---|
| min | $ -18.02 |
| max | $ 54.75 |
| average | $ 11.53 |
| median | $ 5.88 |
| std | $ 13.59 |